Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Bordea E, Caverly E, Chau M, Cohen H, Cullen M, Doré CJ, Engelter ST, Fenner R, Ford GA, Gill A, Hunter R, James M, Jayanthi A, Lip GYH, Massingham S, Murray ML, Mazurczak I, Nash PS, Ndoutoumou A, Norrving B, Sims H, Sprigg N, Vanniyasingam T, Freemantle N; OPTIMAS investigators. Werring DJ, et al. Among authors: hunter r. Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197-4. Online ahead of print. Lancet. 2024. PMID: 39491870 Free article.
Enabling health and maintaining independence for older people at home (HomeHealth trial): a multicentre randomised controlled trial.
Frost R, Avgerinou C, Kalwarowsky S, Mahmood F, Goodman C, Clegg A, Hopkins J, Gould R, Gardner B, Marston L, Hunter R, Kharicha K, Cooper C, Skelton DA, Drennan V, Logan P, Walters K. Frost R, et al. Among authors: hunter r. Lancet. 2023 Nov;402 Suppl 1:S42. doi: 10.1016/S0140-6736(23)02071-8. Lancet. 2023. PMID: 37997084 Clinical Trial.
Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial.
Nielsen G, Stone J, Lee TC, Goldstein LH, Marston L, Hunter RM, Carson A, Holt K, Marsden J, Le Novere M, Nazareth I, Noble H, Reuber M, Strudwick AM, Santana Suarez B, Edwards MJ; Physio4FMD study group. Nielsen G, et al. Lancet Neurol. 2024 Jul;23(7):675-686. doi: 10.1016/S1474-4422(24)00135-2. Epub 2024 May 17. Lancet Neurol. 2024. PMID: 38768621 Free article. Clinical Trial.
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trial.
Panca M, Howard R, Cort E, Rawlinson C, Gould RL, Wiegand M, Downey AM, Banerjee S, Fox C, Harwood R, Livingston G, Moniz-Cook E, Russell G, Thomas A, Wilkinson P, Freemantle N, Hunter RM. Panca M, et al. Among authors: hunter rm. BJPsych Open. 2024 Oct 25;10(6):e189. doi: 10.1192/bjo.2024.775. BJPsych Open. 2024. PMID: 39450544 Free PMC article.
Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Barton K, Wormald R, Morris S, Hunter R, Rubin G, Buszewicz M, Ambler G, Bunce C; LiGHT Trial Study Group. Gazzard G, et al. Among authors: hunter r. Br J Ophthalmol. 2018 May;102(5):593-598. doi: 10.1136/bjophthalmol-2017-310877. Epub 2017 Sep 13. Br J Ophthalmol. 2018. PMID: 28903966 Clinical Trial.
Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease.
Schrag A, Carroll C, Duncan G, Molloy S, Grover L, Hunter R, Brown R, Freemantle N, Whipps J, Serfaty MA, Lewis G. Schrag A, et al. Among authors: hunter r. BMC Neurol. 2022 Dec 12;22(1):474. doi: 10.1186/s12883-022-02988-5. BMC Neurol. 2022. PMID: 36510237 Free PMC article.
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
Blackstone J, Williams T, Nicholas JM, Bordea E, De Angelis F, Bianchi A, Calvi A, Doshi A, John N, Apap Mangion S, Wade C, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson N, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri S, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Nixon SJ, Beveridge J, Hawton A, Tebbs S, Braisher M, Giovannoni G, Ciccarelli O, Greenwood J, Thompson AJ, Hunter R, Pavitt S, Pearson O, Evangelou N, Sharrack B, Galea I, Chandran S, Ford HL, Frost C, Chataway J. Blackstone J, et al. Among authors: hunter r. BMJ Open. 2024 Sep 16;14(9):e086414. doi: 10.1136/bmjopen-2024-086414. BMJ Open. 2024. PMID: 39284697 Free PMC article. Clinical Trial.
Clinical effectiveness of DREAMS START (Dementia Related Manual for Sleep; Strategies for Relatives) versus usual care for people with dementia and their carers: a single-masked, phase 3, parallel-arm, superiority randomised controlled trial.
Rapaport P, Amador S, Adeleke MO, Barber JA, Banerjee S, Charlesworth G, Clarke C, Espie CA, Gonzalez L, Horsley R, Hunter R, Kyle SD, Manela M, Raczek M, Walker Z, Webster L, Yuan H, Livingston G. Rapaport P, et al. Among authors: hunter r. Lancet Healthy Longev. 2024 Oct;5(10):100635. doi: 10.1016/j.lanhl.2024.08.004. Epub 2024 Oct 1. Lancet Healthy Longev. 2024. PMID: 39366393 Free article. Clinical Trial.
2,459 results